HRT Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.47M Sell
14,900
-9,400
-39% -$4.51M 0.01% 924
2026
Q1
$11.9M Buy
+24,300
New +$13.2M 0.03% 552
2023
Q4
– Sell
-1,900
Closed -$961K – 3083
2023
Q3
$961K Buy
+1,900
New +$1.01M 0.01% 1002
2023
Q2
– Sell
-900
Closed -$518K – 3277
2023
Q1
$518K Sell
900
-300
-25% -$169K 0.01% 1354
2022
Q4
$660K Buy
1,200
+300
+33% +$159K 0.01% 1232
2022
Q3
$456K Buy
+900
New +$504K ﹤0.01% 1697

Other funds holding TMO

HRT Financial's TMO Position: Q2 2026 in Review

HRT Financial increased its Thermo Fisher Scientific (TMO) stake by 2,824% in Q2 2026, buying an estimated $7.51M and bringing the position to 16,200 shares worth $8.12M. The position accounts for 0.01% of the portfolio, ranked #873.

HRT Financial first reported a position in TMO in Q3 2019 and has held it in 17 quarters since. The position peaked at $86.2M in Q2 2024. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • HRT Financial held 16,200 shares of Thermo Fisher Scientific worth $8.12M as of Q2 2026.
  • HRT Financial bought 15,646 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.51M.
  • Thermo Fisher Scientific made up 0.01% of HRT Financial's portfolio in Q2 2026, its #873 holding.
  • HRT Financial first reported a position in Thermo Fisher Scientific in Q3 2019 and has held it in 17 quarters since.
  • HRT Financial's Thermo Fisher Scientific position peaked at $86.2M in Q2 2024.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.